Cell Culture Sampling Devices Market

By Devices;

Culture Systems, Incubators, Sterilizer, Centrifuges, Pipetting Instruments, Biosafety Equipment, and Cryostorage Equipment

By Application;

Cancer Research, Gene Therapy, Drug Development, Biopharmaceuticals, and Others

By End User;

Biopharmaceuticals Industry, Academic Institute, Research Laboratories, Clinical Research Organization, and Hospitals

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn465214324 Published Date: August, 2025

Cell Culture Sampling Devices Market Overview

Cell Culture Sampling Devices Market (USD Million)

Cell Culture Sampling Devices Market was valued at USD 3,097.81 million in the year 2024. The size of this market is expected to increase to USD 6,264.70 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 10.6%.


Cell Culture Sampling Devices Market

*Market size in USD million

CAGR 10.6 %


Study Period2025 - 2031
Base Year2024
CAGR (%)10.6 %
Market Size (2024)USD 3,097.81 Million
Market Size (2031)USD 6,264.70 Million
Market ConcentrationLow
Report Pages364
3,097.81
2024
6,264.70
2031

Major Players

  • Thermo Fisher Scientific Inc.
  • Merck KGaA (known as MilliporeSigma in the United States and Canada)
  • Sartorius AG
  • BD (Becton, Dickinson and Company)
  • Lonza Group AG
  • Corning Incorporated
  • GE Healthcare (a subsidiary of General Electric Company)
  • Eppendorf AG
  • Promega Corporation
  • Greiner Bio-One International AG

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Cell Culture Sampling Devices Market

Fragmented - Highly competitive market without dominant players


The Cell Culture Sampling Devices Market is expanding rapidly as laboratories increasingly prioritize contamination-free and precise sampling methods. More than 60% of research and production environments now use advanced sampling technologies to ensure sterility and maintain sample integrity. This surge is largely driven by compliance with strict quality standards in pharmaceutical and biotech sectors.

Automation Enhances Sampling Efficiency
As the use of biologics and cell-based therapies grows, so does the demand for efficient and reliable sampling. Around 45% of modern bioprocessing facilities employ automated sampling devices to reduce manual errors and support consistent monitoring. These solutions are pivotal for optimizing workflows in both research and large-scale production.

Preference for Single-Use Systems
The adoption of single-use systems has fueled interest in disposable cell culture sampling devices, with over 50% of setups incorporating them into upstream processing. These sterile, ready-to-use tools not only reduce contamination risks but also improve operational flexibility, making them ideal for dynamic lab environments.

Technology Integration Driving Market Trends
New sampling technologies with microfluidic capabilities and sensor integration have transformed data collection in cell culture. About 35% of labs have embraced closed-loop, low-volume devices to enable continuous and accurate monitoring. These systems promote efficiency and reduce the need for disruptive interventions during culture processes.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Devices
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Cell Culture Sampling Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological advancements in biotechnology
        2. Rising demand for biopharmaceuticals
        3. Increasing investment in research
        4. Growing prevalence of chronic diseases
        5. Expansion of biotechnology industry
      2. Restraints
        1. High cost of equipment
        2. Ethical concerns over animal testing
        3. Lack of skilled professionals
        4. Stringent regulatory requirements
        5. Contamination risks in culture
      3. Opportunities
        1. Development of 3D cell cultures
        2. Emerging markets in Asia-Pacific
        3. Personalized medicine initiatives
        4. Collaborations with research institutes
        5. Adoption of automation technologies
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Cell Culture Sampling Devices Market, By Devices, 2021 - 2031 (USD Million)
      1. Culture Systems
      2. Incubators
      3. sterilizer
      4. Centrifuges
      5. Pipetting Instruments
      6. Biosafety Equipment
      7. Cryostorage Equipment
    2. Cell Culture Sampling Devices Market, By Application, 2021 - 2031 (USD Million)
      1. Cancer Research
      2. Gene Therapy
      3. Drug Development
      4. Biopharmaceuticals
      5. Other
    3. Cell Culture Sampling Devices Market, By End User, 2021 - 2031 (USD Million)
      1. Biopharmaceuticals Industry
      2. Academic Institute
      3. Research Laboratories
      4. Clinical Research Organization
      5. Hospitals
    4. Cell Culture Sampling Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Thermo Fisher Scientific Inc
      2. Merck KGaA (known as MilliporeSigma in the United States and Canada)
      3. Sartorius AG
      4. BD (Becton, Dickinson and Company)
      5. Lonza Group AG
      6. Corning Incorporated
      7. GE Healthcare (a subsidiary of General Electric Company)
      8. Eppendorf AG
      9. Promega Corporation
      10. Greiner Bio-One International AG
  7. Analyst Views
  8. Future Outlook of the Market